Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Blumberg

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Environmental Health Perspectives|May 3, 2016
Uppsala Consensus Statement on Environmental Contaminants and the Global Obesity EpidemicLars Lind, P Monica Lind, Margareta H Lejonklou, et al.
Biochemical Pharmacology|June 18, 2022
Corrigendum to "Obesity III: Obesogen assays: Limitations, strengths, and new directions" [Biochem. Pharmacol. 199 (2022) 115014]Christopher D Kassotis, Frederick S Vom Saal, Patrick J Babin, et al.
Biochemical Pharmacology|April 8, 2022
Obesity III: Obesogen assays: Limitations, strengths, and new directionsChristopher D Kassotis, Frederick S Vom Saal, Patrick J Babin, et al.
Regulatory Toxicology and Pharmacology : RTP|August 5, 2015
Manufacturing doubt about endocrine disrupter science--A rebuttal of industry-sponsored critical comments on the UNEP/WHO report "State of the Science of Endocrine Disrupting Chemicals 2012"Åke Bergman, Georg Becher, Bruce Blumberg, et al.
The American Journal of Clinical Nutrition|May 25, 2023
Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies WorkshopJerrold J Heindel, Jessica A Alvarez, Ella Atlas, et al.
Blood|September 25, 2020
Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responsesGovindarajan Thangavelu, Chao Wang, Michael Loschi, et al.
Environmental Health : a Global Access Science Source|December 8, 2017
Correction to: Parma consensus statement on metabolic disruptorsJerrold J Heindel, Frederick S Vom Saal, Bruce Blumberg, et al.
Environmental Health : a Global Access Science Source|June 21, 2015
Parma consensus statement on metabolic disruptorsJerrold J Heindel, Frederick S Vom Saal, Bruce Blumberg, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 18, 2014
Characterizing genetic variants for clinical actionErin M Ramos, Corina Din-Lovinescu, Jonathan S Berg, et al.
Environmental Health : a Global Access Science Source|August 29, 2013
Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editorsÅke Bergman, Anna-Maria Andersson, Georg Becher, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Environmental Health Perspectives|May 3, 2016
Uppsala Consensus Statement on Environmental Contaminants and the Global Obesity EpidemicLars Lind, P Monica Lind, Margareta H Lejonklou, et al.
Biochemical Pharmacology|June 18, 2022
Corrigendum to "Obesity III: Obesogen assays: Limitations, strengths, and new directions" [Biochem. Pharmacol. 199 (2022) 115014]Christopher D Kassotis, Frederick S Vom Saal, Patrick J Babin, et al.
Biochemical Pharmacology|April 8, 2022
Obesity III: Obesogen assays: Limitations, strengths, and new directionsChristopher D Kassotis, Frederick S Vom Saal, Patrick J Babin, et al.
Regulatory Toxicology and Pharmacology : RTP|August 5, 2015
Manufacturing doubt about endocrine disrupter science--A rebuttal of industry-sponsored critical comments on the UNEP/WHO report "State of the Science of Endocrine Disrupting Chemicals 2012"Åke Bergman, Georg Becher, Bruce Blumberg, et al.
The American Journal of Clinical Nutrition|May 25, 2023
Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies WorkshopJerrold J Heindel, Jessica A Alvarez, Ella Atlas, et al.
Blood|September 25, 2020
Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responsesGovindarajan Thangavelu, Chao Wang, Michael Loschi, et al.
Environmental Health : a Global Access Science Source|December 8, 2017
Correction to: Parma consensus statement on metabolic disruptorsJerrold J Heindel, Frederick S Vom Saal, Bruce Blumberg, et al.
Environmental Health : a Global Access Science Source|June 21, 2015
Parma consensus statement on metabolic disruptorsJerrold J Heindel, Frederick S Vom Saal, Bruce Blumberg, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 18, 2014
Characterizing genetic variants for clinical actionErin M Ramos, Corina Din-Lovinescu, Jonathan S Berg, et al.
Environmental Health : a Global Access Science Source|August 29, 2013
Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editorsÅke Bergman, Anna-Maria Andersson, Georg Becher, et al.
Pageof 14